Progentos Therapeutics
About:
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Website: https://www.progentos.com
Top Investors: Mission BioCapital, Forbion Capital Partners, Dolby Family Ventures, Alta Partners, Longwood Fund
Description:
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Total Funding Amount:
$65M
Headquarters Location:
Watertown, Massachusetts, United States
Founded Date:
2023-01-01
Founders:
Chris Loose, Sanjay Magavi
Number of Employees:
Last Funding Date:
2024-05-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai